Published in Am J Pathol on September 01, 1991
Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci U S A (2010) 1.42
Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol (1992) 1.34
Microglia in Alzheimer's disease and transgenic models. How close the fit? Am J Pathol (1999) 1.09
Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol (1995) 0.97
Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front Neuroanat (2009) 0.95
The genesis of the senile plaque. Further evidence in support of its neuronal origin. Am J Pathol (1992) 0.84
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Diagnosis of Alzheimer's disease. Arch Neurol (1985) 12.77
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun (1984) 8.14
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11
Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature (1988) 4.83
ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. Am J Pathol (1964) 4.39
A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol (1988) 4.10
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99
Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci U S A (1987) 3.97
The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol (1981) 3.92
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol (1989) 3.58
A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol (1986) 3.09
Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in "normal" patients. Acta Neuropathol (1970) 2.30
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett (1988) 2.26
The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementia. J Neuropathol Exp Neurol (1967) 2.18
Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature (1989) 2.04
Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol (1988) 1.81
Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature (1991) 1.79
Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol (1985) 1.75
A special type of senile plaque, possibly an initial stage. Acta Neuropathol (1987) 1.73
The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 1.68
Senile degenerative brain lesions and dementia. J Am Geriatr Soc (1975) 1.63
A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol (1989) 1.62
Biochemistry of altered brain proteins in Alzheimer's disease. Annu Rev Neurosci (1989) 1.58
Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol (1989) 1.53
Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol (1981) 1.51
In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.51
Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.43
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol (1990) 1.41
Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett (1989) 1.35
Sulfated glycosaminoglycans in amyloid plaques of prion diseases. Acta Neuropathol (1989) 1.26
Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med Hypotheses (1979) 1.24
Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease beta-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol (1989) 1.24
A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science (1989) 1.16
Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol (1990) 1.15
Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science (1990) 1.15
Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease. Biochem Biophys Res Commun (1988) 1.12
beta-amyloid protein of Alzheimer's disease is found in cerebral and spinal cord vascular malformations. Am J Pathol (1988) 1.04
Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol (1990) 1.02
Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest (1990) 1.01
Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem Biophys Res Commun (1989) 0.99
Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am J Pathol (1988) 0.98
The Alzheimer amyloid precursor-related transcript lacking the beta/A4 sequence is specifically increased in Alzheimer's disease brain. Neuron (1990) 0.96
Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Arch A Pathol Anat Histopathol (1987) 0.91
Somatostatin-like immunoreactivity within neuritic plaques. Brain Res (1985) 0.87
Senile plaques are located between apical dendritic clusters. J Neuropathol Exp Neurol (1987) 0.87
Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques. Acta Neuropathol (1990) 0.86
Computerized image-analysis microspectroscopy of tissue sections. Arch Pathol Lab Med (1988) 0.84
An immunohistochemical study of beta-protein in Alzheimer-type dementia brains. J Neurol (1989) 0.83
Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein. Acta Neuropathol (1990) 0.82
Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. Hum Pathol (1988) 0.82
Image analysis microspectroscopy of senile plaque capillary amyloid in Alzheimer's disease. A preliminary study. Arch Pathol Lab Med (1989) 0.76
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science (1987) 12.77
Cerebral amyloid angiopathy. A critical review. Stroke (1987) 4.56
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery (2001) 3.49
High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature (1990) 3.28
Terminology and classification of the cortical dysplasias. Neurology (2004) 2.99
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol (2000) 2.89
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry (2000) 2.37
Cerebral hemispherectomy: hospital course, seizure, developmental, language, and motor outcomes. Neurology (2004) 2.30
Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol (1996) 2.27
Evidence for fibromuscular pulleys of the recti extraocular muscles. Invest Ophthalmol Vis Sci (1995) 2.26
Removing interictal fast ripples on electrocorticography linked with seizure freedom in children. Neurology (2010) 2.23
The neuropathology of AIDS. UCLA experience and review. Am J Pathol (1986) 2.08
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) (1991) 1.89
The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol (2001) 1.86
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol (2000) 1.76
HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J Acquir Immune Defic Syndr (1991) 1.72
Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery (1998) 1.72
Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol (1998) 1.67
CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J Virol (1990) 1.64
Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest (2002) 1.61
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology (2008) 1.59
Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry (1996) 1.58
Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology (2008) 1.57
Posterior cortical atrophy. Neuropathologic correlations. Arch Neurol (1994) 1.56
Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology (1998) 1.55
Neuropathology in older people with disequilibrium of unknown cause. Neurology (1999) 1.54
Hemispherectomy for intractable seizures in children: a report of 58 cases. Childs Nerv Syst (1996) 1.50
Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord (1999) 1.45
Extramedullary plasmacytomas of the head and neck. Otolaryngol Head Neck Surg (1993) 1.44
Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci U S A (1992) 1.41
A beta deposition inhibitor screen using synthetic amyloid. Nat Biotechnol (1997) 1.37
Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol (2001) 1.37
Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol (1992) 1.34
The histotoxicity of cyanoacrylates. A selective review. Neuroradiology (1985) 1.32
Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke (1984) 1.30
Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol (1995) 1.30
Improved outcomes in pediatric epilepsy surgery: the UCLA experience, 1986-2008. Neurology (2010) 1.30
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol (1998) 1.29
Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Biochemistry (1999) 1.27
Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease. Neuroimage (1997) 1.27
Wernicke's encephalopathy in AIDS patient treated with zidovudine. Lancet (1987) 1.24
Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res (1994) 1.22
A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol (1999) 1.21
Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid. J Struct Biol (2000) 1.20
Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol (2012) 1.20
In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Biochemistry (1996) 1.19
Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol (1994) 1.15
Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci U S A (1989) 1.15
Development of the biologically active Guglielmi detachable coil for the treatment of cerebral aneurysms. Part II: an experimental study in a swine aneurysm model. AJNR Am J Neuroradiol (2000) 1.14
Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology (1996) 1.13
Micronodular pneumocyte hyperplasia. Am J Surg Pathol (1998) 1.13
Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology (1997) 1.12
High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. Biochem Biophys Res Commun (1987) 1.11
Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology (2005) 1.11
Dendritic translocation of RC3/neurogranin mRNA in normal aging, Alzheimer disease and fronto-temporal dementia. J Neuropathol Exp Neurol (1997) 1.10
Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci (1997) 1.10
The acquired immunodeficiency syndrome (AIDS) dementia complex. Ann Intern Med (1989) 1.10
Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels. J Neurochem (1987) 1.09
Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997. Epilepsia (1999) 1.09
Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem (1999) 1.07
Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia (1993) 1.04
Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits. Dev Neurosci (2005) 1.04
Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate. N Engl J Med (1986) 1.04
Central nervous system involvement in nephropathic cystinosis. J Neuropathol Exp Neurol (1990) 1.02
Glial cells influence polarity of the blood-brain barrier. J Neuropathol Exp Neurol (1984) 1.02
Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol (1994) 1.02
Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res (1999) 1.01
Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia. Neurology (2007) 1.00
Primary intraventricular hemorrhage in adults. Stroke (1986) 1.00
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta Neuropathol (1996) 0.99
Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg (1991) 0.98
The blood-brain barrier in Alzheimer's disease. Can J Neurol Sci (1986) 0.98
Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol (1992) 0.98
Neuropathologic findings in the acquired immunodeficiency syndrome (AIDS). Clin Neuropathol (1986) 0.97
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience (1995) 0.97
Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? Ann Neurol (2001) 0.97
Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J Neuropathol Exp Neurol (1995) 0.97
Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. Kroc Found Ser (1985) 0.96
Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol (1994) 0.96
Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser (1985) 0.95
Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke (2000) 0.95
Monoclonal antibody to the C-terminus of beta-amyloid. Neuroreport (1994) 0.95
Severe cerebellar degeneration in a patient with T-cell lymphoma. Acta Neuropathol (1986) 0.95
Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol (1997) 0.95
A quantitative analysis of blood-brain barrier ultrastructure in the aging human. Microvasc Res (1987) 0.95
Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol (1995) 0.94
Acute varicella-zoster virus ventriculitis and meningo-myelo-radiculitis in acquired immunodeficiency syndrome. Acta Neuropathol (1993) 0.94
Bilateral neuropathologic changes in a child with hemimegalencephaly. Pediatr Neurol (1997) 0.94
AIDS dementia complex complicated by cytomegalovirus encephalopathy. J Neurol (1993) 0.93
Neurenteric cysts of the spinal cord mimicking multiple sclerosis. Can J Neurol Sci (1981) 0.93
The impact of thromboemboli histology on the performance of a mechanical thrombectomy device. AJNR Am J Neuroradiol (2011) 0.93
Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol (1997) 0.93
White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch Neurol (1995) 0.93
A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest (1992) 0.92
Gerstmann-Sträussler-Scheinker disease: autopsy study of a familial case. Ann Neurol (1986) 0.91